Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 45.26
+1.72 (3.95%)
Mar 6, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 16.66 billion as of March 6, 2026. Its market cap has increased by 39.70% in one year.
Market Cap
16.66B
Enterprise Value
16.73B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.26
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 16.66B, an increase of 119.54%. That is a compound annual growth rate of 13.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 16.02B | -16.67% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 23.70B |
| TransThera Sciences (Nanjing) | 23.44B |
| PegBio | 23.43B |
| InnoCare Pharma | 22.09B |
| Zai Lab | 15.50B |
| Ascletis Pharma | 15.07B |
| Keymed Biosciences | 13.65B |
| Everest Medicines | 12.04B |